Articles
Battling patent expiration by building brand loyalty

Battling patent expiration by building brand loyalty

As pharma faces potential losses due to patent expiration, Kelly Renfro explores how these losses could be combated by building brand loyalty. Over the next few years, a number of blockbuster drugs face patent expiration, including Zyprexa, Xalatan, Crestor and Symbacort. It is estimated that…

Articles
Key European consumer and physician eHealth trends for 2011

Key European consumer and physician eHealth trends for 2011

Increasingly, the internet is becoming used more as a tool for patients and physicians to interact. Is there an opportunity for pharma to become involved in this area – Maureen Malloy and James Avallone discuss research that suggest so. The Internet has drastically changed how both consumers and physicians gather medical information and consume media. This is having a…

Articles
Simple forecasts are best: easy to prove, hard to act on

Simple forecasts are best: easy to prove, hard to act on

When forecasting we can often over complicate matters in the belief that complex forecasts will yield increased accuracy. Gary Johnson explains why we should keep it simple. All good managers know that focus, clarity and simplicity are the hallmarks of good business. And yet, those same managers are …

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more